July 24, 2026

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Strong Buy Ratings and 38% Upside Potential

ArriVent BioPharma, Inc. (AVBP), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to cancer treatment and a..

AMN Healthcare Services Inc (AMN) Investor Outlook: Evaluating Growth in a Dynamic Market

AMN Healthcare Services Inc (AMN), a key player in the healthcare sector, is making waves with its comprehensive suite of technology-enabled workforce solutions and staffing services...

Castle Biosciences, Inc. (CSTL) Investor Outlook: Exploring a 67.89% Potential Upside

Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the healthcare sector specializing in diagnostics and research, is garnering attention from investors due to its impressive..

Altimmune, Inc. (ALT) Stock Analysis: Could a 444% Potential Upside Transform Your Portfolio?

Altimmune, Inc. (NASDAQ: ALT) is capturing significant attention in the biotech sector, a domain known for its dynamic growth and potential for high returns. With a..

Verastem, Inc. (VSTM) Stock Analysis: Exploring a 142% Potential Upside in the Biotech Sector

Verastem, Inc. (NASDAQ: VSTM), a biopharmaceutical company based in Needham, Massachusetts, is garnering significant attention in the biotechnology sector due to its promising oncology drug candidates..

AtaiBeckley Inc. (ATAI) Stock Analysis: Exploring a 33.72% Upside Potential Amidst Clinical Innovations

AtaiBeckley Inc. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company, is carving a niche in the burgeoning field of mental health treatment. With a market capitalization of $2.65..

Autolus Therapeutics plc (AUTL) Stock Analysis: A 462% Potential Upside in the Biotech Arena

Autolus Therapeutics plc (NASDAQ: AUTL) stands out in the healthcare sector, particularly in the biotechnology industry, with its promising potential upside of 462.50%. As a clinical-stage..

Akebia Therapeutics, Inc. (AKBA): Investor Outlook with a Compelling 244% Potential Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company headquartered in Cambridge, Massachusetts, is capturing investor attention with its significant potential upside. With a market capitalization of..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring the 1,160% Potential Upside

Cel-Sci Corporation (NASDAQ: CVM), a biotechnology company entrenched in the healthcare sector, is drawing attention with an extraordinary potential upside of 1,160.50%. As the firm continues..

Arvinas, Inc. (ARVN) Stock Analysis: Unpacking the 82% Potential Upside Amidst Biotech Volatility

Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company based in New Haven, Connecticut, stands at the crossroads of opportunity and challenge, as it endeavors to revolutionize..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Uncovering a 134.5% Potential Upside

Investors with a keen eye on the biotechnology sector might find MeiraGTx Holdings plc (NASDAQ: MGTX) an intriguing prospect. This clinical-stage genetic medicines company based in..

Savara, Inc. (SVRA) Stock Analysis: Biotechnology Gem with Significant Upside Potential

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector, particularly in the biotechnology industry, with its focus on rare respiratory..

Maravai LifeSciences Holdings (MRVI) Stock Report: Navigating Growth in a Volatile Biotech Landscape

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a notable player in the biotechnology sector, offering a wide array of innovative products that support drug therapies,..

iRadimed Corporation (IRMD) Stock Report: Exploring a 25.72% Upside in the Medical Devices Sector

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specifically in the medical devices industry, is gaining attention from investors due to its impressive..

Theravance Biopharma, Inc. (TBPH) Investor Outlook: Analyzing Its 50% ROE and Growth Potential in the Biotech Sector

Theravance Biopharma, Inc. (NASDAQ: TBPH), a notable player in the biotechnology sector, is drawing investor attention with its standout financial metrics, particularly its impressive 50.17% return..

AxoGen, Inc. (AXGN) Stock Report: Exploring the 27.81% Potential Upside in Peripheral Nerve Regeneration

For investors keen on the healthcare sector, AxoGen, Inc. (NASDAQ: AXGN) presents an intriguing opportunity. Operating within the medical devices industry, AxoGen specializes in peripheral nerve..

Myriad Genetics, Inc. (MYGN): Investor Outlook Reveals 9.65% Potential Upside in the Healthcare Sector

Myriad Genetics, Inc. (NASDAQ: MYGN) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. Based in the United States,..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 28.92% Potential Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS) has emerged as an intriguing option for investors looking to capitalize on growth within the healthcare sector, particularly in the medical devices..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 23% Potential Upside with a Strong Dividend Yield

Embecta Corp. (EMBC), a stalwart in the healthcare sector specializing in medical instruments and supplies, has caught the attention of investors with its robust dividend yield..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: Strong Buy Ratings Amid Innovative Biotech Advancements

Investors with a keen eye on the biotechnology sector should take note of Spyre Therapeutics, Inc. (NASDAQ: SYRE), a promising player in the healthcare industry with..

Search

Funds

July 24, 2026

Search

Funds

July 24, 2026

FTSE 100

Funds